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 Severe obesity (BMI ≥35) is increasing at a 2 to 3 times greater rate than Class I 
obesity (BMI 30-34). Successful intervention for the severely obese is primarily limited 
to bariatric surgery, with over 200,000 procedures performed yearly in the U.S. Despite 
an increasing use of bariatric surgery, long-term outcome studies following this 
intervention are very limited, and identification of clinical predictors of bariatric surgery 
durability is lacking. To address these important knowledge gaps, the proposed study will 
draw upon data obtained from long-term prospective gastric bypass study (n=1156) and 
from a gastric bypass patient registry (n=13,500; 1979-2012). These studies will explore 
3 specific clinical questions in patients who have had the most popular bariatric surgical 
procedure, the Roux-en-Y gastric bypass (RYGB). 
• Does cardiorespiratory fitness (CRF) predict 2- and 6-year weight loss following 
RYGB? 
• Does RYGB influence the birth weight of babies born to women post-RYGB 
surgery? 
• Does the age at which RYGB surgery is performed influence longer term 
mortality outcomes? 
      The following aims will be pursued. Aim 1 will test the association baseline and 2-
year CRF with weight loss at 2- and 6-years, respectively. In addition, how well change 
in CRF from 2- to 6-years predicts weight regain 2- to 6-years will be tested. For
 analyses, data collected as part of a 6-year prospective study (n=1156) exploring long-
term morbidity following RYGB surgery will be used. Aim 2 will test the association 
between RYGB surgery and the birth weight of babies born to mothers before and 
following their RYGB surgery. Data from a large RYGB registry (n=13,500) and from 
matched nonbariatric surgery control mothers and their babies will be used to identify 
birth weights using birth certificates from the Utah Population Database. Aim 3 will test 
the association between the age of patients when undergoing RYGB surgery and 
subsequent long-term mortality. Mortality data obtained from the National Death Index 
bureau on post-RYGB surgical patients (n=7925) and matched, nonoperated, severely 
obese Utah drivers license applicants (n=7925), will be used for data analyses. Results for 
these investigations promise to contribute to the clinical understanding of the long-term 
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1-in-3 U.S. adults are estimated to be obese (BMI ≥30 kg/m2).[1] Although 
concerning, a more alarming statistic is the fact that severe obesity (BMI ≥35 kg/m2) is 
increasing at a 2- to-3 times greater rate than Class I obesity (BMI 30-34 kg/m2),[2-5] and 
that the more traditional approaches to weight loss (lifestyle counseling, weight 
management, and pharmacological therapy) are generally insufficient for treating severe 
obesity.[6-8] Even intense medical therapy used in recent randomized control trials has 
demonstrated only 5% weight loss in severely obese participants at 1 to 2 years follow-
up.[9-11] Health-related consequences of severe obesity include an increased rate of 
death[12-14] and increased risk for multiple comorbidities[15] such as type 2 diabetes 
mellitus (T2DM), hypertension, hyperlipidemia, increased inflammatory state, sleep 
apnea, fatty liver disease, and cardiac dysfunction.[16-23] Severe obesity has also been 








Addressing the Dilemma 
To date, the only available medical intervention that has demonstrated substantial 
short- and long-term effects on weight loss in the severely obese population is bariatric 
surgery. [26, 27] Both prospectively controlled cohort studies[6, 28] and randomized 
control trials[9, 10] have reported percentages of initial weight loss among severely obese 
patients undergoing gastric bypass or sleeve gastrectomy procedures to be 25-35% at 1- 
to 2 years follow-up and 25-28% at 6- to 10-years following surgery. In addition, limited 
long-term studies have demonstrated clinically relevant improvements in obesity-related 
conditions such as T2DM remission and improved blood pressure and lipids, with some 
degree of recurrence of these comorbidities over time.[6, 28] Cohort studies have also 
noted a decreased mortality in patients who have undergone bariatric surgery, especially 
from myocardial infarction, diabetes, and cancer-related deaths.[27, 29, 30]  
 
 
Filling the Critical Gap 
Although successful intervention for the severely obese is primarily limited to 
bariatric surgery, long-term outcome studies following bariatric surgery are very 
limited.[31] The National Institutes of Health (NHLBI and NIDDK) recently convened a 
workshop (Bethesda, Maryland, May 2013) to explore what is known and not known 
about long-term outcomes of bariatric surgery. Consensus of the international-based 
participants was that there exists important clinical knowledge gaps related to bariatric 
surgery due to the sparseness of long-term follow-up research studies. Examples of 
limited outcomes research include the assessment of microvascular and macrovascular 




more or less likely to successfully lose and maintain weight loss (i.e., identifying factors 
contributing to the long-term durability of bariatric surgery). To address additional 
important knowledge gaps, the proposed study will explore 3 specific clinical aspects 
related to the long-term effects of voluntary weight loss in patients who have undergone 
the Roux-en-Y gastric bypass (RYGB) surgical procedure.  
 
Bariatric Surgery 
Treating severe obesity.  Although bariatric (weight loss) surgery has been used to 
treat severe obesity for almost 50 years, the increase in popularity has increased only in 
the past 20 years, with a seven-fold increase between 1996 and 2002 (from 3.5 to 24.0 
per 100,000 population).[32] The dramatic rise in popularity of bariatric surgery is 
largely the result of increasing severe obesity, new surgical techniques such as 
laparoscopy, increased safety, favorable weight loss, and improved obesity-related 
comorbidities.[32-38] Recently updated guidelines for the treatment of overweight and 
obesity have been published. With respect to bariatric surgical treatment, adults must 
have a BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with obesity-related comorbid conditions. In 
addition, potential surgical candidates should be “motivated to lose weight” and 
demonstrated that they have not been able to successfully (or adequately) respond to 
traditional lifestyle/behavioral treatment with or without medication therapy.[39] 
Bariatric surgical procedures.  Current procedures include the Roux-en-Y gastric 
bypass (RYGB), adjustable gastric banding, biliopancreatic diversion with duodenal 
switch, and a vertical sleeve gastrectomy. Of these operations, the RYGB is considered to 




with a nine-fold increase in the 1990s.[34, 38]  This operation, now performed almost 
exclusively laparoscopically, reroutes the normal gastrointestinal tract (Figure 1.1a) as 
the stomach and the entire first segment of the small intestine, the duodenum, are 
bypassed (Figure 1.1b). A small proximal pouch of the stomach (15-20 mL) is formed to 
receive ingested foods. As a result of the anatomical alterations resulting from RYGB 
surgery, this procedure is generally recognized as a restrictive and partially malabsorptive 
operation. In addition to the weight loss effects produced by the restrictive and 
malabsoprtive properties of the RYGB procedure, a considerable degree of research is 
onging to understand additonal physiologic-related mechanisms that are likely to be 
associated with the surgery such as hormonal and neuronal alterations,[43] and less 
 
 
Figure 1.1 Description of Roux-en-Y gastric bypass surgical procedure. a. Depiction 
of normal gastrointestinal tract. b. Illustration of the anatomical arrangement 







related to the effects of weight loss. 
Clinical outcomes from bariatric surgery.  Our Utah group has prospectrively 
followed post-RYGB patients as well as 2 severely obese control groups (see “Study 
subjects and study design” section). This study represents the largest and longest 
followed cohort of RYGB patients. Figure 1.2 illustrates the change in BMI from 
baseline to follow-up at years 2 and 6, with projected 10-year follow-up BMI based upon 
data obtained at 2 and 6 years. The longest prospective study related to bariatric surgery 
is the Swedish Obesity Subjects (SOS) study. Initiated in 1987, this study enrolled 2010 
baritric surgical patients and matched severely obese patients (n=2037).[44] The bariatric 
surgical patients underwent 3 different procedures: the vertical banded gastroplasty 
(VBG) (68% of patients); the gastric banding (19%); and RYGB (13%). Unfortunately, 
the VBG is no longer used as a bariatric surgical procedure. The SOS study research team 
has reported on a number of clinical and cost outcomes realted to bariatric surgery.[28, 
44-46] At their 15-year follow-up, the reported percent mean weight loss was 13 ± 14% 
for the gastric banding group, 18 ± 11% for the VBG, and 27 ± 12% for the RYGB 
group. These results support the generally accepted finding that RYGB patients have 
greater initial and extended weight loss when compared to the gastric banding procedure.  
Short-term (2 years postsurgery), RYGB surgery has resulted in substantial 
improvement in major comorbidities.[47-49] Perhaps the most dramatic clinical outcome 
following RYGB surgery has been the rapid remission of type 2 diabetes mellitus 
(T2DM). Where T2DM has generally been considered an irreversible chronic disease 
without hope of remission,[50] remarkably, 80% of type 2 diabetic patients who have 




A1c values and no further use of diabetes medication).[51-54] Further, the remission of 
diabetes is rapid, within 2 days to 2 weeks after RYGB – long before significant weight 
loss.[52, 55] This compelling finding suggests that the rapidity of diabetes remission with 
malabsorptive surgeries such as RYGB occurs through mechanisms independent of 
whole-body obesity reduction.[50, 55, 56] As a result, attention has shifted from fat loss 
to other mechanisms such as insulinotropic gut hormones (particularly the incretin GLP-
1) to explain this nearly miraculous diabetes remission in RYGB patients.[57-60] Our 
Utah group reported a diabetes remission rate at the 2-year exam for diabetics having 
RYGB surgery of 75% (95% CI, 63,87) and 62% (95% CI, 49-75) at the 6-year exam. 
The majority of bariatric surgery studies have reported on weight loss and related clinical 
outcomes over relatively short time periods, with longer term investigations (i.e., 6 years 
or longer) lacking.[61] As a result, significant opportunity exists to exam long-term 
clinical outcomes following bariatric surgery. This study will take full advantage of data 
from a RYGB registry (1979 to present; n=13,500) and of data from a 6-year prospective 




      In conclusion, to address these important knowledge gaps, the proposed study will 
draw upon data obtained from a large, long-term prospective gastric bypass study 
(n=1156) and from a gastric bypass patient registry (n=13,500; 1979-2012). These studies 
will explore 3 specific clinical questions related to the long-term effects of voluntary 
weight loss in patients who have had the most popular U.S. bariatric surgical procedure, 




• Does cardiorespiratory fitness (CRF) predict 2- and 6-year weight loss following 
RYGB surgery? 
• Does RYGB surgery influence the birth weight of babies born to women post-
RYGB surgery? 
• Does the age at which RYGB surgery is performed influence longer term 
mortality outcomes? 
      The 3 aims of this study will address the NIH-identified research gap and will 
increase the understanding of the predictability and durability of this surgical therapy as 
well the role of bariatric surgery on perinatal outcomes. 
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THE ASSOCIATION BETWEEN CARDIORESPIRATORY FITNESS 
AND LONGER TERM WEIGHT LOSS AND WEIGHT REGAIN 
FOLLOWING GASTRIC BYPASS SURGERY 
Background 
 
 Pursuant to the increased interest in bariatric surgery by public and medical 
communities,[1-3] research efforts to identify clinical factors that might predict short- 
and long-term durability following surgery (i.e., weight loss maintenance) have been 
pursued.[4-7] Nonsurgical, conventional-focused weight loss interventions have 
demonstrated participation in physical activity predicts short-term weight loss success [8, 
9] and especially long-term weight loss maintenance.[10] To date, studies relating 
participation in physical activity before bariatric surgery and/or following bariatric 
surgery in relation to postsurgical weight loss outcomes have primarily consisted of 
observational studies using self-reported physical activity recall questionnaire data and a 
few studies using accelerometers with questionnaires.[11-15] Further, these studies have 
generally assessed physical activity engagement for less than 1 year. The reported general 
consensus from these studies is that physical activity increases following bariatric surgery 
and that involvement in physical activity is associated with weight loss. However, there 




measured cardiorespiratory fitness, a marker for participation in physical activity, 
following bariatric surgery. 
 The purpose of this study was to examine the association between long-term 
changes in measured cardiorespiratory fitness and weight loss among patients who 
participated in Roux-en-Y gastric bypass surgery, for the purpose of understanding 
whether or not changes in cardiorespiratory fitness predict weight loss at 2 years and/or 
subsequent weight gain at 6 years follow-up. These data were obtained as part of an 





Subjects for this study were drawn from a prospective controlled study focused on 
the outcomes of Roux-en-Y gastric bypass (RYGB) surgery, whose previous methods 
and results related to baseline, 2 and 6 years follow-up have been previously 
published.[16, 17] The RYGB surgical patients (n=418), operated on by a partnership of 
3 surgeons (Rocky Mountain Associated Physicians, Inc.), were the focus of this study. 
Prior to surgery, these patients had a reported body mass index (BMI) of greater or equal 
to 40 kg/m2 or greater than or equal to 35 kg/m2 and 2 comorbidities, which primarily 
included cardiovascular, sleep apnea, uncontrolled type 2 diabetes, or weight-induced 
physical problems that were interfering with daily functioning. Exclusion criteria for all 
study participants included: previous gastric surgery for weight loss; gastric or duodenal 
ulcers in the previous 6 months; active cancer within the past 5 years (except for 
nonmelanoma skin cancer); myocardial infarction in the previous 6 months; and history 




baseline examination at the University of Utah Center for Clinical and Translational 
Science (CCTS) or a daytime only examination at our center’s outpatient clinic as 
previously described.[17] Of the total 418 RYGB surgical patients, a total of 306 (73%) 
were examined at the CCTS for the overnight study. All participants were invited to 
return for follow-up examinations at 2 and 6 years at the CCTS or outpatient clinic.  
Because clinical tests relevant to this study were only performed at the CCTS, only data 
obtained from RYGB participants examined at this facility were analyzed for this report. 
 
Study Examinations 
This study protocol was approved by the University of Utah Institutional Review 
Board, and prior to participation, signed consent was obtained from all participants. All 
participants were asked to complete a variety of clinical and lifestyle questionnaires and 
undergo anthropometric, biochemistry, and cardiopulmonary testing.[17] Tests specific to 
this study included measurement of height, weight, percent body fat, resting metabolic 
rate, and cardiorespiratory fitness (exercise treadmill test). Height was measured using a 
Harpenden anthropometer (Holtain, Ltd., Crymych, United Kingdom) to the nearest 
centimeter. Weight was measured with a Scaletronix scale (model 5100) (Scaletronix 
Corporation, Wheaton, IL). The scale has an 800-lb capacity and weighing accuracy of 
0.1 kg. Body mass index (BMI) was calculated as body weight divided by height squared 
(kg/m2). The resting metabolic rate (RMR) was measured in the CCTS prior to the 
subject getting out of bed the morning following an overnight stay and a 12-hour fast. 
The RMR was measured using open-circuit indirect calorimetry, using a portable 




ventilated hood. Prior to data collection, the metabolic system was calibrated and patients 
were made familiar with the ventilation hood. Participants were asked to remain 
motionless and encouraged not to sleep during the procedure. Once steady state was 
obtained, the test was continued for at least 10 min. Percent body fat was determined 
from the measurement of resistance and reactance to electrical current using bioelectrical 
impedance equipment (RJL Systems Analyzer; Quantum II, Clinton, MI). Because all 
patients had spent the night in the CCTS and had not eaten food (regular hydration was 
allowed), consumed alcohol, or exercised, all required pretesting criteria for impedance 
analysis were met. All participants were asked to lie in a supine position for at least 5 min 
before the examination. 
The graded exercise treadmill test was conducted in the afternoon when patients 
arrived at the CCTS. Prior to the exercise test, a Mason-Likar ECG-lead placement[18] 
was applied to patients to monitor resting and exercise 12-lead electrocardiogram (ECG).  
Prior to the exercise test, supine and standing blood pressures and heart rates were 
recorded. The stress testing system was comprised of a Marquette Max One System and a 
Marquette 2000 motor-driven treadmill (Marquette Corporation, Milwaukee, WI). The 
electrocardiogram was monitored continuously during exercise by a trained exercise 
technician and a physician was in close proximity during testing. A modified Bruce 
treadmill protocol was used for all tests. The treadmill speed and grade were as follows: 2 
min at stage 1: 1.0 mph, 0% grade; stage 2: 1.7 mph, 0% grade (3 min); stage 3: 1.7 mph, 
5% grade (3 min); stage 4: 1.7 mph, 10% grade (3 min); stage 5: 2.5 mph, 12% grade (3 
min); stage 6: 3.4 mph, 14% grade (3 min); and stage 7: 4.2 mph, 16% grade (3 min). The 




was 1.8, 2.3, 3.5, 4.6, 7.1, 10.2, and 13.5 METs, respectively, where 1 MET = 3.5 ml O2 
uptake per kg body mass per min. Participants were encouraged to exercise using the 
handrails only for balance (not to support their body weight during the test) to 80% of 
their age-predicted maximum heart rate (220—age) at which point the test was 
discontinued. Other indications for stopping the test included abnormal ECG, heart rate 
or blood pressure responses, participant malaise, equipment failure, or at the discretion of 
the supervising physician.[19] The subject’s perceived exertion (6–20 Borg point scale) 
was recorded at the end of each stage. Blood pressure and heart rate were recorded during 
the last 30 seconds of each stage of exercise and at immediate, 3 and 6 min recovery. 
Total exercise time in min was also recorded. Exercise testing was conducted by an 
exercise test technologist with a cardiologist in close proximity and was completed in 
accordance with published clinical guidelines.[19] While study investigators opted for 
submaximal testing (using a modified Bruce protocol) to avoid potential harm or 
discomfort that may be incurred during maximal exercise testing in patients whose 
functional capacity is limited by deconditioning or existing disease,[17] the baseline 
testing results demonstrated that from a clinical point-of-view, the patients tolerated well 
the submaximal test. As a result, for the 2- and 6-year cardiorespiratory tests, participants 
were asked to exercise to their full capacity, or maximal effort. Finally, the income 
categories were ascertained using a 1 to 6 scale: 1, less than $9,999; 2, $10,000 to 
$29,000; 3, $30,000 to $49,000; 4, $50,000 to $69,000; 5, $70,000 to $99,000; and 6, 







Using patient data obtained before and following Roux-en-Y gastric bypass 
surgery, multiple linear regression was used for statistical analyses. The 3 specific aims 
of this study focused on whether cardiorespiratory fitness (CRF), represented by total 
treadmill time, measured at baseline and 2 years predicted change in body weight at 2 and 
6 years, respectively (Aims 1 and 2), and whether or not change in body weight from 2 to 
6 years (i.e., 6-year weight minus 2-year weight) was associated with 2- to 6-year change 
in CRF (i.e., 6-year CRF minus 2-year CRF) (Aim 3). Testing Aims 1 and 2 included 
regressing change in body weight from baseline to 2 years (dependent variable) with CRF 
measured at baseline (independent variable), as well as associating weight change from 2 
to 6 years with CRF measured at 2 years. These analyses were adjusted for baseline 
weight (Aim 1 regression analysis) and for year 2 weight (Aim 2 regression analysis). 
Change in body weight from 2 to 6 years was then regressed with change in CRF from 2 
to 6 years (Aim 3). For Aim 3 regression analysis, the covariates of weight at 2 years, 
resting energy expenditure (REE) measured at 2 years, treadmill time at 2 years, and the 
change of REE from 2 to 6 years (i.e., 6-year REE minus 2-year REE) were added to the 
model. Finally, in an attempt to represent CRF relative to total muscle mass, this 
regression analysis scheme was repeated as previously described replacing the Aim 3 
variable of change in total treadmill time from 2 to 6 years with the variable with 6-year 
total treadmill time divided by fat-free mass measured at year 6 minus the 2-year total 
treadmill time divided by fat-free mass obtained at year 2. Comparison of mean 
differences for 2 and 6 years for specific variables (age, weight, income, total treadmill 




Student t-test.  Significance level was set at p < 0.05 and the study data were analyzed 




 A descriptive representation of the subjects and variables used for this study are 
presented in Table 2.1. Of the 306 Roux-en-Y gastric bypass (RYGB) patients who 
participated in the overnight examination at the CCTS, 295 (96%) underwent a baseline 
exercise treadmill test, with 273 of these participants having resting metabolic rate 
measured. These 295 RYGB were on average 42.5 years of age (± 10.7 years), 133.9 
kilograms (± 25.9 kilograms), and 85% were female. As expected, weight at the 2-year 
examination decreased to a mean of 87.8 kilograms (± 21.8 kilograms), representing a 
34.4% reduction in initial body weight. Body weight measured at the 6-year examination 
increased by 5.2% (7.0 kilograms, p=0.003) compared to the 2-year body weight (mean 
6-year examination equal to 94.8 ± 23.0 kilograms). The total treadmill time at baseline 
was equal to 576.0 ± 197.5 seconds and represented 80% of the patient’s predicted 
maximal heart rate. As detailed in the methods section, for the 2- and 6-year 
examinations, participants were encouraged to exercise to their maximal effort. The 
change in maximal total treadmill time from 2 to 6 years was 37.4 seconds, or a 4.4% 
decrease (p=0.029). The resting energy expenditure (REE) from baseline to the 2-year 
examination decreased by 430.9 kcal/day (19.8% decrease) but from 2 to 6 years, the 
change in REE was not significantly different (p=0.957). While the reduction in fat free 
mass (FFM) from baseline to 2 years was 14.3 kilograms (23% reduction; p<0.0001), the 




significantly different (p=0.23). With reference to 2- and 6-year CRF measurement, at 2 
years, 221 RYGB surgical patients returned to the CCTS for overnight testing (72% 
follow-up compared to baseline) and 217 (98%) underwent an exercise treadmill test. At 
year 6, 161 RYGB patients returned to the CCTS (73% follow-up compared to year 2; 
53% follow-up compared to baseline), and 156 (97%) participated in an exercise 
treadmill test. 
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*Baseline total treadmill time related to submaximal cardiorespiratory test (i.e., 80% of 
predicted maximal heart rate). 
**Total treadmill time related to maximal cardiorespiratory test. 
†p<0.0001 for 2 year results compared to 6 year results. 
***p<0.01 for 2 year results compared to 6 year results. 





 Results related to Aims 1 and 2, whether or not cardiorespiratory fitness (i.e., total 
treadmill time) measured at baseline and at year 2 predicted weight change from baseline 
to year 2 and from year 2 to year 6, respectively are detailed in Table 2.2. Once change in 
weight from baseline to year 2 in association with baseline treadmill time was adjusted 
for baseline weight, baseline total treadmill time no longer predicted weight change 
measured at year 2 (p=0.945). Similarly, year 2 total treadmill time in association with 
weight change from 2 to 6 years, when adjusted for year 2 weight, was not significant 
(p=0.385). Analyses for Aim 3, whether or not change in CRF (total treadmill time) from 
2 to 6 years predicted 2- to 6-year weight change, are detailed in Table 2.3. The 




Table 2.2. Beta Coefficient, Standard Error, and P Value for Change in Weight from 
Baseline to 2 years in Relation to Total Treadmill Time Measured at Baseline, and 
for Change in Weight from 2 to 6 Years in Relation to Total Treadmill Time 
Measured at Year 2. Adjustments Included Within Models 1 and 2. 
 Statistical M
odels 
Covariates Change in Weight 2 from 
Baseline to 2 years (Dependent 
Variable) in Reference Total 
Treadmill Time Measured at 
Baseline (Independent 
Variable) 
Covariates Change in Weight from 2 to 6 
Years (Dependent Variable) in 
Reference Total Treadmill 




















0.0097 0.0046 0.038 Total 
Treadmill 
Measured 
at 2 years, 
min/kg 
0.0036 .00052 0.509 






-0.0003 0.0041 0.945 Total 
Treadmill 
Measured 
at 2 years, 
min/kg 












Table 2.3. Beta Coefficient, Standard Error, and P Value for Change in Weight From 
2 to 6 Years in Relation to Change in Total Treadmill Time (With and Without 
Relative Representation by Fat Free Mass). Progressive Adjustments Included Within 





Covariates Change in Weight 2 to 6 
Years (Dependent Variable) 
in Reference to Total 
Treadmill Time (Independent 
Variable) 
Covariates Change in Weight 2 to 6 Years 
(Dependent Variable) in Reference 
to Total Treadmill Time/Fat Free 
















2 to 6 
Years, min 





from 2 to 6 
Years, 
min/kg 
-1.579 0.223 <0.0001 
 




2 to 6 
Years, min 





from 2 to 6 
Years, 
min/kg 
-1.524 0.225 <0.0001 
 Female 1.005 2.249 0.45 Female -0.511 1.198 0.797 
 Age -0.162 0.084 0.055 Age -0.111 0.759 0.144 










-1.468 0.226 <0.0001 
 Female 0.118 2.920 0.04 Female -0.833 2.515 0.741 
 Age -0.146 0.091 -1.60 Age -0.110 0.783 0.163 
 Income -0.471 0.674 0.486 Income 0.009 0.585 0.988 
 2 Year 
Weight, kg 
-0.092 0.735 0.214 2 Year 
Weight, kg 
-0.124 0.062 0.048 
 2 Year 
REE*, 
Kcal 
0.006 0.005 0.198 2 Year 
REE*, Kcal 
0.011 0.004 0.017 








-0.020 0.006 0.002 
 Change in 
REE from 






REE from 2 
to 6 Years, 
Kcal 
0.021 0.004 <0.0001 
 




2.3, respectively, demonstrated that change in total treadmill time from 2 to 6 years, 
relative and not relative to fat free mass, significantly predicted the change in weight 
change from year 2 to year 6 (p values ranging from 0.001 to 0.002 for total treadmill 
time and <0.0001 for treadmill time relative to fat free mass).  In addition, treadmill time 
measured at year 2 and change in resting energy expenditure from 2 to 6 years were also 
significant for predicting change in 2- to 6-year weight. Figures 2.1 and 2.2 are graphical 
representations of the unadjusted association between 2- to 6-year weight change and 
change in CRF 2 to 6 years (Figure 2.1) and unadjusted association between 2- to 6-year 
weight change and change in total treadmill time/fat free mass 2 to 6 years (Figure 2.2). 
The respective R2 values for Tables 2.1 and 2.2 were 0.08 and 0.38, respectively.  
 
Discussion 
To our knowledge, this study represents the first long-term study (i.e., 2 years or 
greater) tracking change in weight and cardiorespiratory fitness following Roux-en-Y 
gastric bypass surgery. These results demonstrated that although submaximal and 
maximal cardiorespiratory fitness as measured by total treadmill time at baseline and at 2 
years, respectively, did not predict weight change from baseline to 2 years or weight 
change from 2 to 6 years when adjusted for baseline and 2-year weight, respectively, 
change in cardiorespiratory fitness from 2 to 6 years was significantly associated with 2- 
to 6-year weight change. Further, when total treadmill time was divided by change in fat 
free mass from 2 to 6 years, change in weight from 2 to 6 years was even more 
significantly associated with change in cardiorespiratory fitness. 






Figure 2.1: Scatter Plot of Change in Weight from 2 to 6 Years in Patients Following 
Roux-en-Y Gastric Bypass Surgery Associated with Change in Total Treadmill Time 
from Year 2 to Year 6. 
 
 
Figure 2.2 Scatter Plot of Change in Weight from 2 to 6 Years in Patients Following 
Roux-en-Y Gastric Bypass Surgery Associated with Change in Total Treadmill Time 
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based on the measurement of respiratory gas exchange using indirect calorimetry analysis 
during maximal exertion. [20, 21] This study opted to assess CRF with a submaximal 
treadmill exercise test (using a modified Bruce protocol) as part of the baseline 
examination and then employ maximal exercise testing (same modified Bruce protocol) 
for years 2 and 6 examinations. This type of submaximal and maximal exercise testing 
protocols have been highly correlated with laboratory measures of maximal 
cardiorespiratory fitness (CRF) that use respiratory gas analysis.[20, 22] In an attempt to 
understand CRF in relation to the lifestyle-related aspects of physical movement, 
previously published reviews have carefully delineated the difference between physical 
fitness and cardiorespiratory fitness.[23-26] In a more general sense, the term “physical 
fitness” has reference to a “variety of characteristics” that are found within the broader 
categories of cardiorespiratory fitness; body composition, strength, and flexibility.[26] 
From this description, fitness has been further identified as one’s capability of engaging 
in moderate to vigorous physical activity during the course of one’s life.[26, 27] Within 
this context, one would naturally conclude that the opportunity to increase physical 
fitness (or cardiorespiratory fitness) and its associated health benefits would require a 
person to engage in repeated bouts of physical activity.[23, 28] 
 However, for patients who undergo RYGB surgery, postsurgery changes in CRF 
(i.e., increased total treadmill time) may likely be due to factors in addition to their 
increased participation in physical activity. The improved total treadmill time following 
RYGB surgery may also be linked to the very significant and sustained weight loss (i.e., 
greater than or equal to 50 kilograms), improved musculoskeletal function, and enhanced 




treadmill test. In fact, in this Utah study, although baseline fitness predicted change in 
weight loss from baseline to year 2, this prediction was no longer significant once 
adjustment was made for baseline weight. The very large percentage of weight loss (35% 
of initial weight from baseline to 2 years) simply overwhelmed all other possible weight 
loss prediction-related factors. 
Investigators of the long-term Swedish Obesity Subjects (SOS) study have 
reported that obese women who have had bariatric surgery report a lower 2- and 6-year 
incidence of knee and ankle joint pain (OR, 0.51 to 0.71).[29] In addition, although the 
SOS follow-up approach for participation in physical activity was limited to self-reported 
questionnaire, over a 2- to 10-year follow-up period, the postbariatric surgical patients 
did report an increase in their participation in physical activity.[30, 31] Based upon these 
findings, the authors surmise that just as physical inactivity “contributes” to the 
development of obesity,[32] the obesity state may further promote physical 
inactivity,[33] creating a downward spiraling cycle. Further, bariatric surgery may well 
break this cycle,[33] resulting in the postoperative patient’s ability to move with less 
challenge (i.e., pain and discomfort) and to engage in being physically active (leisure or 
otherwise) with greater energy efficiency. This logic may suggest that RYGB patients 
participating in this Utah study were able to significantly extend their total treadmill time 
because of improved energy efficiency (i.e., reduced total fat mass) at specific 
submaximal workloads.  
 The findings from this Utah study, that changes in total treadmill time from year 2 
to 6 predicted change in weight during the same follow-up period, may support the notion 




as measured by greater treadmill time, are the reasons for postoperative RYGB patients to 
maintain and/or regain less weight over time (i.e., from 2 to 6 years). Post-RYGB surgery 
patients typically reach their nadir of weight loss around 2 years and then generally 
regain approximately 5 to 7% of the total weight loss during the next few years. 
Therefore, the finding that greater CRF over the 2- to 6-year period predicted less weight 
regain is an important clinical finding and provides support for postoperative patients and 
their caregivers to strongly encourage regular participation in physical activity. 
 While this study did not provide self-reported measures of participation by 
patients in physical activity, there are a number of observational studies using self-
reported physical activity recall questionnaire data and a few studies using 
accelerometers with questionnaires to assess degree of physical activity participation 
following bariatric surgery,[11-15] although these studies have generally assessed 
physical activity engagement for less than 1 year. The reported general consensus from 
these studies is that physical activity increases following bariatric surgery and that 
involvement in physical activity is associated with weight loss. As indicated, the unique 
aspect of the Utah study was long-term measurement of CRF using an exercise treadmill 
test. To date, there are very little data assessing direct measurement of CRF change 
before and following bariatric surgery. In a study of 109 patients with severe obesity 
(mean BMI 48.7 ± 7.2; range, 36.0 to 90.0 kg/m2), medical charts were abstracted to 
obtain CRF measured prior to their undergoing RYGB surgery. Following surgery, the 
lowest tertile of CRF (< 15.8 ml/kg/min) was significantly associated with greater short-
term postsurgical complications (p=0.02) compared to patients whose presurgical CRF 




test) on 65 consecutive severely obese patients before, 6 and 12 months following RYGB 
surgery. The time on treadmill for the 3 measurement periods was 5.4 ± 1.4, 6.4 ± 1.6, 
and 8.8 ± 1.0 min, respectively. These values represented a significant increase from pre-
op to 6- and 12-months post-op (p=0.001).[34] A similar study measured CRF before and 
1 year following bariatric surgery (type of surgery was not indicated) in 31 severely 
obese patients. The time on treadmill was significantly increased at 1-year post-op 
compared to pre-op (13.8 ± 3.8 to 21.0 ± 4.2 min; p<0.001). The authors also noted that 
patients performed each specific workload at a “lower oxygen consumption” and heart 
rate post-operatively compared to that obtained before surgery, suggesting that following 
bariatric surgery, patients were able to perform physical-related work at a lower energy 
expenditure.[35] These data support the findings of our Utah study and the notion that 
obese persons may expend greater energy performing the same amount of work as a more 
normal weight individual.[36] That is, perhaps the severely obese person simply requires 
(or expends) greater energy (cardiovascular and otherwise) to move their large body 
mass.[35] 
Also unique to this study was the measurement and subsequent adjustment of 
resting energy expenditure (REE) and fat free mass. When REE measured at year 2 and 
change in REE from 2 to 6 years were included as covariate adjustments for change in 
weight and change in treadmill time (2 to 6 years), REE was shown to be highly related 
to 2- to 6-year weight change. Although a significant reduction in REE was from baseline 
to year 2 was shown in this study (a result of reduced total mass and fat free mass), the 
high degree of association between change in REE and favorable weight loss change (i.e., 




may be a favorable predictor of weight loss maintenance. Finally, because energy is 
primarily consumed within muscle mass, total treadmill time relative to fat free mass was 
used in this study to better access the energy efficiency of the RYGB patients both before 
and following their surgery. Indeed, the change in total treadmill time relative to fat free 
mass increased the significance of the association with 2- to 6-year weight change. 
 Limitations of this study include the use of a submaximal exercise treadmill test 
(i.e., 80% of predicted maximal heart rate) at baseline but a maximal-based treadmill test 
at years 2 and 6. The reason for the decision to vary the study protocol and shift to a 
maximal exercise test was because maximal exercise tests are deemed to more accurately 
predict maximal CRF. However, the change in protocol between baseline and year 2 
disallowed for any comparison in change in CRF (i.e., difference in total treadmill time) 
during this time period. However, the opportunity to assess change in treadmill time 
during the critical period when most RYGB surgery patients regain weight was possible 
(i.e., both years 2 and 6 were maximal CRF tests). The low participation rates at year 6 
were also a limitation of this study. A number of study patients chose to come to our 
outpatient clinic for the 6-year examination rather than spend the night at the CCTS, and 
a treadmill test was not available at our outpatient clinic. However, a high percentage of 
patients who did choose to return to the CCTS for 2- and 6-year examinations also agreed 
to undergo a maximal exercise test (95% plus). We recognize that there is a high 
probability that those patients who did not return for participation at year 2 and year 6 
may be study participants who were not as successful with weight loss or weight loss 
maintenance and may have also represented those who were less physically active. 




CRF from year 2 to 6 predicted the more favorable weight loss change outcome. 
 Strengths of this study include a very large number of RYGB surgical patients 
studied before and at 2 and 6 years following their surgery. As previously indicated, this 
study represents the only long-term follow-up of RYGB patients where CRF has been 
measured, rather than assumed due to favorable self-reported physical activity 
questionnaires following surgery or accelerometer data. 
In conclusion, previous studies related to physical activity and associated 
cardiorespiratory fitness among the bariatric surgery population have been limited to 
assessment short-term postsurgical follow-up. The findings of this study are the first to 
demonstrate that favorable changes in CRF following RYGB surgery can have a positive 
influence upon reducing the risk of long-term weight regain following surgery. These 
findings also support clinical guidelines that recommend patients undergoing bariatric 
surgery should be well-informed of the importance to build in a lifetime of participation 
in physical activity following surgery. 
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ASSOCIATION OF GASTRIC BYPASS ON GESTATIONAL AGE 
AND WEIGHT OF CHILDREN BORN BEFORE AND  





 Long-term, clinically relevant sequelae of obesity include an increased risk for 
female infertility, maternal and perinatal pregnancy complications such as miscarriage, 
Cesarean section, gestational diabetes, hypertension, and fetal macrosomia.[1-6] 
Increased pregnancy-related health risks are especially apparent among severely obese 
women. [5, 6] Women who have participated in bariatric surgery represent an ideal 
population to appraise whether or not prepregnancy voluntary weight loss in severely 
obese women improves fertility and significantly reduces maternal and infant pregnancy 
complications. Studies have demonstrated that bariatric surgery results in significant and 
sustained weight loss[7, 8]; however, during the period of major weight loss (within the 
first 12 to 18 months following surgery) and perhaps thereafter, food intake restriction 
and/or malabsorption may inhibit maternal nutrient intake and compromise fetal 
growth.[4, 9, 10] Therefore, greater understanding of the benefits and risks associated 
with pregnancy following bariatric surgery has important clinical importance. Acquiring 




the increasing number of pregnant women who have undergone bariatric surgery. This 
increase is due to 3 factors: bariatric surgery is increasing in popularity;[11-13] 
approximately 80% of all bariatric surgical procedures are performed on women;[14, 15] 
and a significant percentage of bariatric surgeries are undertaken during the female’s 
reproductive years.[4] 
This study builds upon previously reported investigations that have related 
pregnancy and bariatric surgery, but have employed wide variation in methodological 
approaches.[16-24] Using a large population of post-gastric-bypass women and a unique 
population-based, nonsurgical patient matching design, the aim of this study was to 
further test the association between gestational age and birth weight pregnancy outcomes 






Two primary study populations were included in the study, surgical patients and 
nonsurgical subjects (see Figure 3.1). The surgical population consisted of a consecutive 
series of 5,819 female residents of Utah who had previously undergone Roux-en-Y 
gastric bypass surgery (RYGB) between 1979 and 2011 (performed by 6 bariatric 
surgeons representing a single Utah surgical practice, Rocky Mountain Associated 
Physicians, Inc.) and their live births (n=13,112). These surgical patients were linked 
with the Utah Population Database (UPDB), which holds Utah records for 15 million 
individuals connected from various sources, including genealogy records, inpatient 





Total RYGB Mothers and Total Pregnancies 
 
RYGB Mothers:              5,819 
Total Live Births:         13,112 
D. Unmatched RYGB 
Mothers Who had 
Pregnancies Before and/or 





Live Births Before 
Surgery: 
5,954 
Live Births After 
   Surgery: 
1,312 
 
Additional Unmatched Live 
Births of RYGB Mothers 
from Groups 1 and 2 (i.e., 
only the closest pregnancy 
before surgery and/or closest 
pregnancy following surgery 
were part of live birth 
matching in A and B – all 
other unmatched live births 
from A and B mothers are 
accounted for below)  
   
Unmatched Births  
   Before Surgery:            
254 
Unmatched Births 
   Following Surgery:      
589 
 
A. Matched Nonsurgery 
Mothers and their 
Pregnancies Matched to the 
RYGB Mother’s Closest 
Pregnancy Before Surgery 
and to First Pregnancy 
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1,059 
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295 
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   Following Surgery: 
295 
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Live Birth Closest to 
   Following Surgery: 
469 
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Live Birth Closest to 
   Before Surgery: 
3,944 
Figure 3.1. Roux-en-Y Gastric Bypass and Matched Nonsurgical Mothers and Neonates. 
Total Unmatched Nonsurgery 









certificates.[25] Once linked, pregnancy patterns of all RYGB women were ascertained 
for the purpose of matching and statistical analyses. The nonsurgical population included 
Utah females (n=525,653) who had not undergone bariatric surgery and their live births 
(n=1,071,767), whose data were part of the UPDB (Figure 3.1). This population was used 
for matching purposes. Allocation of the surgical and nonsurgical subjects is detailed in 
Figure 3.1: matching (A and B); and nonmatched (C and D). 
 
Study Groups 
Three groups were considered for the purpose of analyses. Figure 3.2 illustrates 
the methods-related schemes employed for each of the groups. Groups 1 and 2 included 
matching of surgical and nonsurgical subjects, while Group 3 consisted only of RYGB 
patients. For study Group 1, the matching focused on RYGB mothers whose pregnancies 
had occurred both before and after RYGB surgery (see Figure 3.2; Group 1). Using the 
UPDB birth certificate records, nonsurgery women and their respective pregnancy data 
were matched 1-to-1 to these RYGP mothers and pregnancies. The following matching 
criteria were used: mother’s birth year or birth age; mother’s race (white/nonwhite); birth 
year for the neonate born closest to pre-RYGB surgery and birth year for the neonate 
born closest to post-RYGB surgery; birth order for the 2 pregnancies closest to pre- and 
post-RYGB surgery; total parity; birth multiplicity (i.e., singletons and twins); and 
prepregnancy BMI (kg/m2) self-reported on the birth certificate of the RYGB mother for 
her pregnancy closest and prior to her RYGB surgery. The specific intent of analysis for 
Group 1 was to compare the neonate born to the RYGB mother closest to and before her 

































Group 1: Children born before and after Roux-en-Y gastric bypass surgery (RYGB) 
Mother A: RYGB 
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parity, birth order 
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Mother B: No RYGB 
Group 2: Children born after RYGB surgery only combined with children born 
after surgery in Group 1 above (see dotted line). 
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Group 3: All children born before and after Roux-en-Y gastric bypass surgery to 











neonate born to the RYGB mother closest to and following her surgery with the matched 
neonate of the nonsurgical mother (see Figure 3.2; Group 1). 
Study Group 2 included a combination of 2 matched subgroups (see Figure 3.2, 
Group 2). The first subgroup (see Figure 3.2, Group 2a) included 1-to-1 matching of data 
of the RYGB mothers whose pregnancies had occurred only after her RYGB surgery. 
Data of the mother and her live birth associated with the first pregnancy that occurred 
after her RYGB surgery were matched with the data of the nonsurgery mother and her 
neonate. The matching criteria used for Group 2a included the mother’s birth year or 
birth age; mother’s race (white/nonwhite); birth year of the neonate of the closest 
pregnancy following RYGB surgery; birth order (in this case, the closest child born to the 
RYGB and the nonsurgical mothers (i.e., closest pregnancy that occurred after RYGB 
surgery); total parity; birth multiplicity (singleton and twins); and prepregnancy BMI 
(kg/m2) of the RYBG mother measured just prior to her RYGB surgery. As depicted in 
Figure 3.2 by the dashed line, Group 2b (the post-RYGB surgery component of Group 1) 
was also included as part of Group 2 analysis (i.e., RYGB mother’s neonates from Group 
1 who represented the first pregnancy following surgery and their matched nonsurgical 
mother’s neonates). The objective for Group 2 was to facilitate analysis of mothers and 
their live births that occurred following their RYGB surgery compared to matched 
nonsurgery mothers and their neonates. Categories used for matching prepregnancy BMI 
were: 18.5 to 24.9; 25.0 to 29.9; 30.0 to 34.9; 35.0 to 39.9; 40 to 49.9; and ≥ 50. Group 3 
did not involve maternal or neonate nonsurgical matching (see Figure 3.2, Group 3). 
Rather, this scheme simply included all live births of all RYGB women that had occurred 




RYGB surgery, without specific reference to birth order for mothers with multiple births 





Prepregnancy BMI was not reported on birth certificates in Utah prior to 1989 and 
as a result, nonsurgical women could only be selected from births occurring after 1989. 
Because Utah birth certificates do not give information on the total number of 
pregnancies, for the purpose of this study, parity was defined as total live births. Using 
this definition, a combination of 2 approaches were used to assess parity: 1) the 
maximum number of previous live births listed on a given mother’s set of birth 
certificates; and 2) the total number of live born children available in UPDB. These 2 
methodologies were used because the number of previous live births is not always 
accurately recorded and there may have been children born outside of Utah who would 
not be counted using the second approach. When the RYGB mother/pregnancy was part 
of a multiple birth set, all children in the set of multiple births were used, but they were 
required to match to a corresponding nonsurgery multiple birth. No RYGB women were 
selected as nonsurgery matched patients. Subsequent to the initial matching of RYGB- 
and nonsurgical-related subjects, where the majority of matches occurred, the matching 
criteria were somewhat relaxed. These conditions included combining the 2 BMI groups 
of 40 to 49.9 and ≥ 50, grouping parity and birth order if ≥ 5, and extending the child’s 
birth year and/or the mother’s birth year from ±1 year to as much as ± 3 years. When the 




year was used so the birth intervals and mother’s age at time of birth would be consistent 
for the subgroup where pregnancies occurred both before and after RYGB surgery. The 
percentage of exact matches for all subgroups combined was 78%. 
Following the matching of patients and their pregnancies with nonsurgery 
mothers and their pregnancies, pregnancy-related information was extracted from the 
respective birth certificates. Birth weight, gestational age at birth, and Apgar scores at 1 
and 5 min were obtained for all pregnancies. Additional maternal information extracted 
from the birth certificate included: age at delivery, race (white or nonwhite), Hispanic 
(yes or no), self-reported weight gain during pregnancy, smoker (yes or no), and self-
reported maternal height and weight prior to becoming pregnant were extracted from the 
birth certificates. The actual surgical date of gastric bypass patients was used to calculate 
the time between the closest delivery prior to RYGB surgery and surgery as well as the 
time from RYGB surgery to the closest delivery occurring after surgery. The extraction 
of maternal- and neonatal-related complications were also extracted from each birth 
certificate and results from these data will be analyzed and reported in a subsequent 
report. 
Two sets of criteria were used to clinically evaluate the birth weight of 
newborns.[26, 27] One birth weight guideline focused solely on the absolute weight of 
the baby, without reference to the gestational age when birth occurred. These criteria 
identified macrosomia, also referred to as high birth weight (HBW), as greater than 4000 
grams (8 pounds 13 ounces) with 2 low-related birth weight ranges; very low birth weight 
(VLBW) less than 1500 grams (3 pounds 5 ounces), and low birth weight (LBW) less 




defined as a birth weight between 2500 and 4000 grams (5 pounds 8 ounces to 8 pounds 
13 ounces). The second criteria for birth weight status related the infants birth weight to 
gestational age (weeks) at birth. These criteria were sex dependent and included 3 
categories: large for gestational age (LGA), which was a birth weight greater than the 90th 
percentile of birth weight for a given gestational age; appropriate for gestational age 
(AGA) indicated by a birth weight between the 10th and 90th percentile in relation to 
gestational age; and small for gestational age (SGA), less than the 10th percentile of birth 
weight in relation to gestational age. For additional clinical analysis, gestational age at 
birth (measured in weeks) criteria included < 37 weeks as preterm, 37 to 41 weeks as 
normal term, and > 41 weeks as extended term.  
 
Statistical Analysis 
A t-test was used to assess how well the RYGB subgroups were matched with the 
nonsurgical groups (i.e., age of mothers, birth year of babies, and self-reported BMI) and 
presented as means ± standard deviations.  A Χ2 test was used to compare frequency 
differences between the RYGB and nonsurgical maternal race (white/nonwhite), Hispanic 
(yes/no), and smoking. For analyses of Groups 1 and 2 (matched surgical and nonsurgical 
subjects), conditional logistic regression, adjusted for sex of the neonate, was used to 
determine the odds ratios and 95% confidence intervals between the 2 study groups with 
reference to birth weight (with and without reference to gestational age at birth) and to 
gestational age at birth. For Group 3, (no subject matching) logistic regression, adjusted 
for sex of neonate, mother’s age at delivery, number of previously born children (i.e., 




pregnancies was used to test for birth weight and gestational age at birth. For Group 3 
logistic regression analysis of the birth weight category less than 1500 grams, there was 
repeated measures adjustment for multiple pregnancies due to the small sample size. 




 Figure 3.1 details the number of matched mothers and live births for Groups 1 and 
2, with Group 1 including 295 matched surgical and nonsurgical mothers and 295 before- 
and 295 after-RYGB surgery matched live births. Group 2 (Groups 2a and 2b combined) 
contained 764 total matched mothers and 754 matched neonates who were all born the 
first pregnancy following RYGB surgery. Group 3 (unmatched subjects) included 5819 
mothers who had live births both before RYGB surgery (n=4931 births) and/or live births 
following surgery (n=2,666 births). Table 3.1 includes maternal and pregnancy-related 
descriptive characteristics for each of the 3 groups. For Groups 1 and 2, the mean 
maternal age at delivery (pre- and post-RYGB surgery) were not significantly different 
between the surgical and nonsurgical mothers (p=0.53 for both pre- and postsurgery). For 
Group 1, differences in prepregnancy BMI (self-reported birth certificate) for matched 
surgical and nonsurgical mothers prior to RYGB surgery were 36.1 ± 6.5 and 35.1 ± 6.2 
kg/m2, respectively (p<0.0001) and as expected, post-RYGB surgery prepregnancy BMI 
difference between surgical (27.6 ± 5.5 kg/m2) and nonsurgical women (36.7 ± 7.7 
kg/m2) for Group 2 was significantly different (p<0.0001). In Group 3, the prepregnancy 
BMI of all RYGB surgery mothers prior compared to following surgery was also, as 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































race was predominantly white among all 3 groups (range, 94-96.6%), with 5.8 to 11% 
maternal Spanish reported among the groups. Little variation was seen between groups 
for total parity (range of 2.5 to 3.8) and nonsingleton births ranged from 2 to 5.5% across 
groups. The only significant difference in Apgar score was seen in Group 3 where the 1 
min Apgar score was significantly greater for pre- vs. post-RYGB pregnancies (7.55 ± 
1.41 vs. 7.63 ± 1.35; p=0.009). There were no significant differences, however, for the 5-
min Apgar scores for Group 3. For Group 1 (pre- and postsurgery) and Group 2, the 
RYGB surgical mothers had significantly greater reported pregnancy weight gain when 
compared to the matched, nonsurgical mothers, all with a p value of <0.0001. There were 
no reported differences in percentage of smokers between surgical and nonsurgical 
mothers for Groups 1 and 2, but for Group 3, the percentage of smokers for pre- versus 
post-RYGB surgery mothers was 3.0 vs. 7.5%, p<0.0001. post-RYGB surgery mothers 
was 3.0 vs. 7.5%, p<0.0001. 
Birth weight and gestational age data for Groups 1-3 are detailed in Tables 3.2-
3.4. When comparing the matched surgical and nonsurgical neonates born closest to and 
before RYGB surgery (Group 1; Table 3.2), there were no differences in odds ratios (OR) 
for birth weight or gestational weeks categories when compared to the referent groups. 
However, pregnancies related to Group 1 that were the first births following RYGB-
surgery showed surgical neonates were significantly less likely to be born greater than 
4000 grams (OR, 0.28; 95% CI, 0.11 to 0.61; p=0.0025) and a lower risk to be born large 
for gestational age (LGA) (OR, 0.16; 95% CI, 0.07 to 0.33; p<0.0001) compared to 
nonsurgical born neonates. Although not significant, there was a trend for surgical 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































small-for-gestational-age (SGA) (OR, 2.20; 95% CI, 1.02-5.16; p=0.054). 
RYGB Group 2, which focused only on the neonates born to RYGB mothers and 
nonsurgical matched mothers of the first pregnancy following RYGB surgery (Table 3.3), 
showed pregnancies of the surgical mothers were significantly less likely to extend 
beyond 42 weeks gestation compared to nonsurgical pregnancies (OR, 0.53; 95% CI, 
0.30 to 0.91; p=0.024). In addition to a significantly smaller mean birth weight for 
neonates of surgical mothers compared to nonsurgical born neonates (3092 ± 568 vs. 
3292 ± 696 grams; p<0.0001), neonates born to surgical mothers also had a significantly 
lower risk for a birth weight greater than 4000 grams or being born LGA (p<0.0001). 
However, the risk for having a SGA birth was significantly greater for the neonates born 
to RYGB surgical mothers compared to nonsurgical born neonates (OR, 2.16; 95% CI, 
1.43 to 3.32; p=0.0003). Group 3 results (Table 3.4), contrasting all neonates born before 
surgery to all neonates born following RYGB surgery, were quite polarized with regards 
to the birth weight and gestational age categories. While neonates born to postsurgical 
mothers were at a significantly lower risk for deliveries greater than 42 weeks (OR, 0.23; 
95% CI, 0.19 to 0.28; p<0.0001) compared to presurgical neonates, the postsurgery 
neonate deliveries were at a significantly greater risk to occur less than 37 weeks (OR, 
1.93; 95% CI, 1.62 to 2.31; p<0.0001) compared to presurgical deliveries. This same 
pattern was evidenced in the results for LGA and SGA, where the postsurgical born 
neonates were significantly lower in risk for LGA (OR, 0.22; 95% CI, 0.18 to 0.27; 
p<0.0001), while at the same time there was a significantly greater risk for SGA (OR, 







 In view of the increased number of bariatric surgical procedures now undertaken 
in the U.S., with near 80% of all surgeries performed on females, there is an important 
clinical need to understand and appreciate potential benefits and risks of pregnancy in 
women following participation in bariatric surgery. This study of a large number of 
women who had undergone Roux-en-Y gastric bypass (RYGB) surgery and had 
experienced live birth pregnancies before and/or after RYGB surgery showed that 
following surgery, the risk of giving birth to a large-for-gestational-age neonate is 
significantly lower when compared to neonates born to matched, nonoperated mothers. 
However, study results also indicated that post-RYGB women were at a greater risk to 
deliver a small-for-gestational-age neonate. 
 Obesity has been associated with an increased risk for female-related fertility 
problems, especially related to ovulatory function.[1, 2] Obesity has also been associated 
with pregnancy complications, including an increased risk for miscarriage, C-section, 
gestational diabetes, and hypertension.[3, 4] In addition to complications related to the 
obese pregnant mother, prepregnancy maternal BMI has had a positive association with 
neonatal complications, including fetal macrosomia, high birth weight (HBW), and large-
for-gestational-age (LGA) born neonates.[3, 4, 28-30]. In a recently published systematic 
review and meta-analysis of 45 studies comparing prepregnancy normal-weight mothers 
to prepregnancy obese mothers, there was a reported increased risk for LGA (OR, 2.08; 
95% CI, 1.95-2.33), with similar odd ratios for macrosomia and HBW.[30] The incidence 
of LGA for live births in the U.S. in 2008 was 6.6.[31] The incidence of LGA reported 




LGA neonates/total neonates), or almost twice the U.S. incidence. This rate (11.9%) is 
somewhat less than the 16.4% LGA births reported Getahun et al., in a longitudinal study 
of over 12,000 live births born to obese women.[29]  
In addition to maternal complications related to LGA, infants born with the 
diagnosis of LGA are a greater risk for a wide-variety of comorbidities.[32] Further, 
LGA-born neonates have an increased metabolic risk profile in childhood,[30, 33, 34] 
during adolescents,[35, 36] and into adulthood.[37] Thompson et al., tracking the 
National Health and Growth Study (NGHS) population to adulthood, reported children 
with reported onset obesity prior to age 12 years were 11 to 30 times more likely to 
present with obesity as adults. In addition to increased obesity risk, the overweight/obese 
NGHS children had a greater incidence of hypertension, hyperlipidemia, and metabolic 
syndrome as adults.[38]  
 Despite the significant positive association between maternal prepregnancy 
obesity and neonatal LGA, HBW, and macrosomia, studies have reported that even a 
minimal reduction in a woman’s BMI may result in improved health status as well as 
lower risk for pregnancy-related complications,[17, 39] and that reduction in 
prepregnancy BMI can reduce the risk for LGA.[29, 40] A longitudinal retrospective 
study by Getahun et al., (2007) examined the first 2 consecutive singleton live births 
(n=146,227) to determine the association between prepregnancy BMI and LGA for their 
mother’s first pregnancy and in contrast, the association between prepregnancy BMI and 
LGA for the same mother’s second pregnancy. Results from this study indicated that 
when a mother’s first prepregnancy BMI was in the obese range and subsequently 




overall risk of her having a LGA birth was reduced.[29] 
If minimal weight reduction has been shown to improve pregnancy-related 
outcomes, then it should follow that weight loss from bariatric surgery would also result 
in reduced pregnancy complications for the mother and the newborn. In this Utah study, a 
significantly lower risk (p<0.0001) for high birth weight neonates (i.e., greater than 4000 
grams) and for LGA neonates was evidenced when pregnancies of women who had 
undergone RYGB surgery were compared to matched pregnancies of nonoperated 
women (Groups 1 and 2), and when outcomes for live birth weights were compared 
between pregnancies that occurred before RYGB surgery and pregnancies after surgery 
(Group 3). These data represent a 67 to 84% reduction in risk for LGA births among the 
post-RYGB mothers when compared to nonoperated matched mothers or neonates born 
to RYGB surgery mothers prior to their surgery. A study by Kjaer et al. compared 
singleton deliveries following bariatric surgery (n=355 women with at least one live birth 
following surgery; 83.5% RYGB surgical procedures) to nonbariatric surgical women, 
matched for prepregnancy BMI, maternal age, and date of delivery.[16] They reported a 
lower risk for LGA births among the postbariatric surgical women compared to the 
nonoperated group (OR, 0.31; 95% CI, 0.15 to 0.65), or a 69% reduction in LGA risk. 
Although maternal and neonatal complications related LGA-related pregnancies are not 
reported as part of the Utah study, these data were collected as part of the birth certificate 
and plans are to analyze these outcomes in relation to LGA in the near future. 
In contrast to the significantly lower risk for high birth weight and LGA among 
neonates born to post-RYGB surgery mothers compared to matched nonsurgical mothers, 




(SGA) births for post-RYGB surgery pregnancies. These findings of a greater risk for 
SGA following surgery were highly significant for Groups 2 and 3 and borderline 
significant for Group 1 (p=0.054). With the exception of a study by Kjaer et al.[16] and 
our Utah study, previous bariatric surgery pregnancy-related studies have only reported 
and increased risk for SGA birth when the bariatric surgery pregnancy outcomes have 
been compared to non-BMI matched populations.[4] The odds ratios for SGA of 2.20, 
2.16, and 2.25 between postsurgical neonates and BMI-matched nonsurgical neonates for 
Groups 1, 2, and 3, respectively, of the Utah study are very similar to the odds ratio of 2.3 
reported by Kjaer et al. who compared the first pregnancy following bariatric surgery of 
339 women BMI-matched to nonsurgery mothers.[16]  Small-for-gestational-age birth 
has been shown to be associated with a greater future risk for both diabetes and the 
metabolic syndrome for these babies.[41, 42] Although some SGA neonates may simply 
be smaller than normal as a result of their parents being small, cause for most SGA births 
appear to be associated with intrauterine growth restriction (IUGR), a condition that 
results from the fetus failing to receive adequate nutrients and oxygen for appropriate 
growth processes.[43] Roux-en-Y gastric bypass results in an anatomical bypassing of all 
but a small pouch of the stomach and the entire duodenum. As a result of the 
malabsorptive aspect of this surgery, there is the potential risk for nutritional deficiencies 
of the mother and the fetus. Subanalysis of the RYGB surgery mother’s weight gain 
patterns for pregnancies occurring after their surgery suggested that although pregnancy 
weight gain was significantly greater for mothers who delivered LGA neonates compared 
to weight gain of mothers delivering AGA babies, there were no significant differences 




pregnancy weight gain of mothers delivering AGA babies. This may suggest that of the 
possible risks for a post-RYGB surgery mother having an SGA neonate, too little weight 
gain during pregnancy may not to be one of them. Long-term outcomes of SGA-born 
neonates have not been described. However, a study by Smith et al. that followed 111 
siblings (age 2.5 to 26 years) who were born before and following maternal bariatric 
surgery (biliopancreatic diversion; a malabsorptive procedure) reported the children born 
following the surgery had a more favorable metabolic risk when compared to the children 
born before surgery.[44] Further, Guénard et al. analyzed the impact of maternal weight 
loss resulting from bariatric surgery by analyzing differential methylation in 
glucoregulatory genes (i.e., potential pathways involved with improved cardiometabolic 
processes) and markers for insulin resistance between offspring born before and after 
their mothers participated in bariatric surgery (n=25 before and 25 after surgery; ages 2 to 
25 years).[45] The after-surgery sib had lower HOMA-IR, insulin, and blood pressure 
compared to before-surgery sibs, with over representation in glucoregulatory, 
inflammatory, and vascular disease pathways.[45] These results suggested potential 
epigenetics factors may influence the postbariatric surgical pregnancy outcome. Finally, a 
recent meta-analysis of 45 studies contrasted prepregnancy underweight, normal-weight, 
and overweight/obesity of women with SGA and LGA.[30]  Overweight/obese 
prepregnancy increased the risk of LGA and high-body weight (HBW), whereas 
prepregnancy underweight was reported to increase the risk for SGA as well as low-body 
weight (LBW). However, the likelihood of post-RYGB surgery women reaching a BMI 
considered to be underweight is minimal.  




ascertaining data through birth certificates. For example, the maternal prepregnancy BMI 
obtained from birth certificates (self-reported) of the neonate born closest to and before 
RYGB surgery may be less than the measured presurgery, prepregnancy BMI. It was this 
self-reported prepregnancy BMI that was used to match to the nonsurgical mother and 
her neonate, a match that could have resulted in a nonsurgical mother whose 
prepregnancy BMI was less than the RYGB prepregnancy BMI. However, if the 
nonsurgery mother’s prepregnancy BMI were lower than that of the surgical mother, the 
statistical comparison for LGA should be conservative (i.e., with a lower nonsurgical 
mother’s BMI, one would expect a lower rate of LGA births). Further, analyzing SGA in 
the context of a lower nonsurgical mother’s BMI should also be conservative because one 
would hypothesize the nonsurgical mother to have a greater risk for SGA (lower mean 
prepregnancy BMI) in comparison to a greater prepregnancy BMI. Other limitations 
include the possibility of overmatching of the surgical mothers and neonates to the 
nonsurgical mothers and neonates.[46] This study design represented matching on more 
variables than any other bariatric surgery pregnancy study has employed. Therefore, the 
opportunity to adjust for various pregnancy-related factors was not possible. An 
additional limitation was that all clinical variables of the patients and subjects are self-
reported and limited to birth certificate extraction (i.e., recorded by the delivering 
physician, nurse, or allied health professional). 
 To our knowledge, this study represents the first study to compare pregnancy 
outcomes both closest to and before surgery and first after surgery pregnancy among 
RYGB surgery patients and neonates with prepregnancy, BMI-matched, nonoperated 




post-RYGB surgery women and their offspring, with a high statistical power to detect 
differences in pregnancy outcomes before and following surgery (Group 3). Finally, the 
use of the Utah Population Database to provide matching between RYGB patients and 
respective birth certificates as well as to match to population-based, nonsurgical subjects 
and their pregnancies (i.e., 525,653 mothers and 1,071,767 live births) is deemed a 
strength of this investigation.  
 In conclusion, this uniquely designed study which explored pregnancy outcomes 
of RYGB surgical patients before and/or after surgery clearly demonstrated that 
following RYGB surgery, women are at a significantly reduced risk for having an LGA 
live birth. The short- and long-term clinical benefits of this reduced LGA risk are likely 
to be substantial. These results also indicate that post-RYGB surgery mothers are at a 
significantly greater risk to deliver an SGA neonate. The increased risk for SGA delivery 
raises considerable clinical concern related to potential nutritional deficiencies for both 
the mother and the developing fetus, a potential direct result of the restrictive and 
malabsorptive nature of this bariatric surgery. Greater exploration related to mechanisms 
that may account for the increased SGA risk following RYGB surgery as well as clinical 
surveillance of these SGA-born neonates during childhood, adolescence, and adulthood 
to determine long-term SGA outcomes are warranted. 
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ASSOCIATION OF PATIENT’S AGE AT GASTRIC BYPASS  






 The opportunity to explore the equivocal association between voluntary weight 
loss and long-term mortality [1, 2] has been made possible by studying patients who have 
undergone bariatric surgery, a treatment that results in significant and sustained weight 
loss.[3, 4] Since the initial retrospective mortality study by MacDonald et al., comparing 
diabetic patients who underwent gastric bypass surgery and diabetic patients who were 
seeking but did not have surgery,[5] a number of controlled retrospective bariatric 
surgery mortality studies,[6-12] a few retrospective studies without control groups,[13, 
14] and one prospective matched control study[15] have been reported. In addition, at 
least 2 bariatric surgery meta-analysis studies related to long-term mortality have been 
published.[16, 17] From these data, the general consensus has been that long-term all-
cause mortality and most often, cardiovascular- and cancer-specific mortality is favorably 
impacted for patients who have previously undergone bariatric surgery. One reported 
exception was a study by Maciejewski et al.[12] whose study included strict propensity 




surgical and control groups who were followed for an average of 6.7 years. Unique to this 
study was the inclusion of bariatric surgical and nonoperated patients of Veterans Affairs 
medical centers who represented an older mean age (mean 49.5 years) and a much greater 
proportion of males (77.9% males) compared to other bariatric surgery studies.[12] 
Further, at least 2 retrospective mortality studies have reported increased rates of deaths 
related to suicides, poisonings of undetermined intent and non-drug-related accidents 
among postbariatric surgical patients compared with nonoperated subjects.[6, 18] 
 From these long-term mortality data, at least 2 important clinical-related questions 
arise. Does the reported mortality benefit for all-cause and cause-specific deaths extend 
to all bariatric surgical patients regardless of what age they undergo surgery?  Second, 
does the age at which bariatric surgery is performed have an association with future risk 
of death from external causes of death, such as suicide, poisonings and accidents?  
Drawing upon a previously published long-term mortality study of Utah-based 
Roux-en-Y gastric bypass patients,[6] the primary aim of this investigation was to test the 
association between age-specific all-cause and cause-specific mortality among postgastric 
bypass patients matched to severely obese nonoperated subjects. Results from this study 
may provide clinicians with additional information to share with patients who are 
considering bariatric surgery or who have undergone surgery and may be deemed at 















This investigation was approved by the Institutional Review Board of the 
University of Utah. Requirements established by federal and state governments to 
maintain strict confidentiality were followed during the course of the study. Selection of 
subjects for this age-stratified retrospective study has been previously described.[6] In 
brief, from a consecutive series of 9949 post-Roux-en-Y gastric bypass patients and 9628 
severely obese (BMI ≥ 33 kg/m2) Utah drivers license and identification (ID) applicants, 
one-to-one matching was performed for 7925 patients and nonoperated subjects. 
Matching criteria included sex, BMI, age (with 5-year categories), and year of surgery 
matched with the year of application for a driver’s license or ID card. The BMI matching 
was conducted using 3 BMI categories: 33 to 44, 45 to 54, and 55 (kg/m2) or more, with 
the surgical patients presurgical BMI used to match with the nonoperated subjects’ 
adjusted, self-reported BMI (methods used to produce sex-specific, correction regression 
equations have been previously described[6]). Data obtained on all matched, nonoperated 
subjects were cross-referenced with all gastric bypass patients and with the Utah Health 
Department’s hospital registry to eliminate any of these subjects who had previously 
undergone bariatric surgery from 1992 to 2002. Gastric bypass patients and severely 
obese, nonoperated groups were stratified in 4 age-group intervals: less than 35 years; 35 
to 44 years; 45 to 54 years; and greater than 55 years. All subject data were linked to the 
Utah Cancer Registry (part of the National Cancer Institute’s Surveillance, 
Epidemiology, and End Results program) to eliminate cases of prevalent cancer and were 




death as categorized by ICD-9 and ICD-10 classifications. The NDI used name, sex, date 
of birth, and Social Security number (when reported) and probability-based 
algorithms[19] to match the gastric bypass and nonoperated groups with their national 
death database. Finally, a series of sensitivity-based measures, previously described,[6] 




Using Cox proportional-hazards regression analysis, the risk of death between the 
Roux-en-Y gastric bypass and the matched nonoperated subjects group for each of the 4 
specific age categories was performed. Each age group was analyzed separately and 
within these separate analyses, sex was stratified. For each age category, the survival time 
was computed as the difference between the date of death for decedents, or January 1, 
2003 for survivors, and baseline date, defined as the date of bariatric surgery for the 
patient group and the date of drivers license or ID card application for the nonoperated 
group. Similar to the previous study, sex, baseline age, year of bariatric surgery or the 
year of license or ID application, and a cubic polynomial of BMI at baseline were used in 
the statistical model for each age category. The absolute death rates (unadjusted) are 
represented as deaths per 10,000 person-years of follow-up. The p-values and the 95% 
confidence intervals are all 2-sided and criteria used for statistical significance was a p-












Table 4.1 highlights the descriptive data for all Roux-en-Y gastric bypass patients 
and all matched nonoperated subjects as well as the data for age-specific categories, 
including number of subjects per age category, sex, BMI, and follow-up in years and 
person-years. While there were no significant differences between the 2 groups for mean 
follow-up time for all ages combined and for age-specific categories, mean BMI was 
consistently greater (p<0.0001) for the nonoperated groups (all and age-specific) 
compared to the surgical group. Over the total follow-up period of 18 years (mean of 7.1 
years), there were 213 and 321 total deaths reported for the postsurgical and nonoperated 
groups, respectively (Table 4.2). Total deaths (i.e., all-cause mortality) were consistently 
greater among the nonoperated controls within the age-specific groups, with the 
exception of the less than 35 years old subgroup, where the surgical group reported 69 
all-cause mortality deaths compared to 50 total deaths for the nonoperated subjects. The 
primary reason for the higher number of deaths among the operated versus nonoperated 
groups in the less than 35 years of age category was due to externally caused deaths, 
where the surgical deaths were 63 and the nonoperated subject deaths were 36. Deaths 
caused by all diseases (defined as all deaths except externally-caused deaths), 
cardiovascular disease, and cancer were reduced among the surgical patients compared to 
the corresponding nonsurgical subgroups within the combined age group and each 
separate age category (Table 4.2). 
As previously published,[6] the rate of death related to all-cause mortality for all 
ages combined was 40% lower among the gastric bypass group when compared to the 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































0.67); p<0.0001) (Table 4.3). Further, for all ages combined, the deaths caused by 
accidents unrelated to drugs, poisonings of undetermined intent, suicide, and other 
nondisease causes were 1.58 times as great for the gastric bypass group compared to the 
nonoperated subject group (HR 1.58; 95% CI, 1.02 to 2.45; p=0.04) (Table 4.3). The less 
than 35 years of age category showed a HR value of 1.22 (95% CI, 0.82 to 1.81; p=0.34) 
for all-cause mortality when the surgical was compared to the nonsurgical groups, and 
this increased risk, while not significant, appeared to primarily be the result of a 2.53 
times greater death for external causes (95% CI, 1.27 to 5.07; p=0.009) in the surgical 
patients compared to the nonsurgical subjects less than age 35 years. Otherwise, with 
reference to all external caused deaths, there were no significant differences for the other 
3 age categories greater than 35 years. With the exception of the less than 35 years age 
category, all other age categories showed a significantly lower percentage for all deaths 
caused by disease among the surgical patients versus the nonoperated subjects, (57%, 
61%, and 54% for ages 35-44, 45-54, and greater than 55 years, respectively). Death 
from all cardiovascular disease and from all cancers were significantly lower for the post-
gastric bypass group compared to the nonoperated subjects for ages 45-54 years (p=0.003 
and p=0.02 for cardiovascular deaths and cancer deaths, respectively), with a similar 
trend for the ages 35-44 years and greater than 55 years age categories (p=0.08 and 
p=0.12, respectively, for cardiovascular deaths and p=0.16 and p=0.19, respectively, for 
cancer deaths). Figures 4.1 through 4.4 illustrate the hazard ratios and 95% confidence 





































































































































































































































































































































































































































































































































































































































































































































































































































































This study extends a previously published long-term mortality study of patients 
who have undergone Roux-en-Y gastric bypass surgery as compared to a severely obese 
population of nonoperated subjects by analyzing all-cause and cause-specific mortality of 
4 specific age groups; less than 35 years, 35 to 44 years, 45-54 years, and greater than 55 
years. All-cause mortality was significantly lower among all surgical age groups greater 
than 35 years compared to the nonoperated subjects. While all-cause death was not  
significantly different between groups for the < 35 years of age category (HR 1.22; 95% 
CI, 1.22 to 1.81; p=0.34), the HR for all external caused deaths for the youngest age 
category (<35 years) was 2.53 (p=0.009) for the surgical patients compared to the 
nonoperated group. These results would suggest that patients who participate in gastric 
bypass surgery at a younger age (i.e., less than 35 years) are at a greater risk for death 
from external causes such as accidents unrelated to drugs, poisonings of undetermined 
intent, and suicide. Further, study results indicate that gastric bypass surgery is associated 
with a lower mortality risk for cardiovascular disease- and cancer-related deaths 
irrespective of age at surgery. 
The positive association between all-cause mortality and severe obesity has been 
well established,[20] with the recent systematic review and meta-analysis of Flegal et al. 
of more than 2.9 million subjects and 270,000 deaths reporting a hazard ratio of 1.29 
(95% CI, 1.18 to 1.41) for all-cause mortality among grades 2 and 3 obesity (i.e., ≥ 35 
kg/m2) compared to normal weight BMI (18.5 to less than 25 kg/m2).[21] However, 
whether or not voluntary weight loss in individuals who are overweight or obese results 




epidemiological research reporting a worsened mortality following weight loss.[22] 
Although somewhat limited, and with some differences in methodological approach, 
longer term mortality studies of patients who have undergone voluntary weight loss 
through bariatric surgery have almost without exception reported a reduction in all-cause 
mortality as well as reduced death rates from certain diseases such cardiovascular disease 
and cancer.[6-15] From these studies has evolved the clinical message that severely obese 
patients who are contemplating bariatric surgery can generally expect a longer life if they 
undergo such surgery. However, at least 2 important clinical questions (or considerations) 
have arisen with regards to the expected benefit of improved mortality following bariatric 
surgery. 
The first question is whether or not a patient can expect extended life expectancy 
through reduction of deaths from such illness as cardiovascular diseases and cancer 
regardless of their age at the time of bariatric surgery, (i.e., do mortality benefits extend 
to bariatric patients regardless of age at surgery). Shorter term bariatric surgery mortality 
studies (i.e., greater than 30 days to 2 years following surgery) have suggested patients 
who undergo surgery at an older age have higher mortality rates.[23-25] In an analysis of 
90-day and 1-year postbariatric surgery all-cause mortality of 16,155 Medicare 
beneficiaries, Flum et al. reported mortality rates were greater for patients 65 years or 
older when compared with younger patients (6.9% vs 2.3% at 90 days and 11.1% vs. 
3.9% at 1 year, p<0.001).[25] Perry et al. conducted a retrospective cohort mortality 
analysis following bariatric surgery up to 2 years on Medicare fee-for-service patients 
who had received bariatric surgery (n=11,903) compared to one-to-one matching of 




increased survival rates compared to the nonoperated patients with up to 2 years of 
follow-up, but noted that the reported survival advantage began 6 months postoperatively 
for surgical patients under age 65 years and at 11 months for patients over age 65 
years.[26]  Whether or not a similar, less-favorable mortality outcome for older patients 
undergoing bariatric surgery persists longer term (i.e., greater than 2 years) when 
compared to nonoperated BMI matched subjects has only been reported in one study [12] 
prior to this Utah-based age-stratified report. This single retrospective cohort study of 
bariatric surgery programs in Veterans Affairs medical centers compared 850 veterans 
who had undergone bariatric surgery to propensity-matched nonoperated veterans 
(n=1694) using clinical information. The analysis comparing the 2 groups reported 
bariatric surgery not to be significantly associated with reduced mortality (HR 0.94; 95% 
CI, 0.64 to 1.39; mean follow-up, 6.7 years).[12] The mean age of the surgical cohort was 
49.5 ± 8.3 years and predominantly males (74%) compared to our Utah study of 39.5 ± 
10.5 years and only 16% males. In addition, our Utah study did not have access to 
clinical information other than sex and BMI for use in matching to the nonoperated 
subjects. Further, Maciejewski et al. reported the veterans to be “sicker patients” 
compared to other bariatric surgery studies and stated that “it is possible that bariatric 
surgery reduces mortality for younger patients and not for older male patients.”[12] 
Contrary to the results of Maciejewski et al., our Utah study reported significantly 
improved long-term mortality for each of the 3 age groups over age 35 years and in 
addition, deaths from cardiovascular disease and cancer were significantly lower for 
postsurgical patients compared to nonoperated subjects for ages 45-54 years, with a 




A second question is whether or not there are specific clinical factors that might 
predict which bariatric surgical patients are at greater risk for death from non-disease-
related deaths such as suicide, poisonings of undetermined intent, and non-drug-related 
accidents (referred to by the NDI as “external-related deaths”). Importantly, the Utah 
study has provided an insight to this question by demonstrating that the significant risk 
for these external causes of death were largely limited to patients who had undergone 
gastric bypass surgery at less than 35 years of age (i.e., HR 2.53; 95% CI, 1.27 to 5.07; 
p=0.009). In fact, this increase in deaths from external causes among patients whose 
surgery was performed before the age of 35 years may have accounted for the lack of 
significantly greater all-cause mortality among this age group. Omalu et al. computed 
death rates of all bariatric patients in Pennsylvania (1995 to 2004; n=16,683 patients; 440 
deaths) from the state’s division of vital records.[18] Omitting the bariatric surgical 
patients, death rates were then derived from the entire Pennsylvania population without 
regards to BMI. They reported a significantly higher death rate for suicide and drug 
overdoses of undetermined intent among the surgical patients compared to the general 
nonoperated population, with most of these deaths having occurred more than one year 
following bariatric surgery.[18] There are possible contributing reasons for increased 
externally-caused deaths following some bariatric surgeries. Although limited, 
observational studies may suggest that some procedures such as gastric bypass may 
increase the long-term risk for substance use disorders[27-29] and suicide.[30] In an 
ongoing prospective cohort study being conducted by our Utah group, we have reported 
that health-related quality of life was significantly more impaired in patients seeking 




follow-up of this study, although health-related quality of life was improved among the 
surgical group, they did not have an improved SF-36 mental health component.[4] The 
SF-36 is a widely used psychometric survey used to provide a general assessment of 
physical and mental health perception.[32] As Livingston has pointed out, there is a 
“great deal of overlap” between mental health disorders and obesity.[33] In addition to 
the potential increased risk for substance use disorders, there may exist postsurgical 
dissatisfaction related to presurgical expectations in comparison with postsurgical 
outcomes. Clearly, additional research related to the behavioral/psychological aspects 
before and following bariatric surgery, perhaps especially in the younger aged 
population, is warranted. 
Limitations related to this study included the lack of clinical information prior to 
or following surgery or drivers license application, with the exception of BMI, age, and 
sex. As a result, whether or not the gastric bypass patients were of similar health status as 
the nonoperated subjects prior to surgery or whether or not greater medical attention was 
provided for postsurgical patients as a result of their surgical entry into the medical 
system were not known. Potential bias related to self-reported height and weight among 
the drivers license and ID card applicants may have been present, despite the sex-specific 
regression correction. Other potential biases related to NDI matching have been 
previously described.[6] Finally, there were a more limited number of subjects within the 
greater than 55 years of age group, which may have reduced the power for detecting 
cause-specific death differences between the surgical patients and nonoperated subjects in 
this higher age group. Strengths of this study included a rather unique matching design as 




years. The opportunity to divide mortality results into separate age categories was also 
unique to this study. 
Despite limitations, this study implies gastric bypass surgery is protective against 
cardiovascular and cancer mortality for all age groups. With the exception of increased 
external causes of death in younger patients (i.e., suicide, poisonings of undetermined 
intent, and accidents not related to drugs), gastric bypass surgery also significantly 
reduces all-cause mortality rates, even for patients who undergo surgery at an older age. 
Further investigations are warranted to better understand and predict risk for externally-
caused deaths among post-gastric-bypass patients, especially among surgical patients 
whose surgery is performed at an earlier age (i.e., less than 35 years). 
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 As indicated in the introductory comments of this dissertation, weight loss surgery 
has as its primary aim significant and sustained weight loss for the severely obese 
population. The estimated number of bariatric surgeries performed worldwide in 2011 
was 340,768,[1] and in the U.S., the most commonly performed bariatric surgery is the 
Roux-en-Y gastric bypass (RYGB) (Figure 1.1b).[2, 3] As highlighted, this operation, 
now primarily performed laparoscopically, reroutes the normal gastrointestinal tract (see 
Figure 1.1a) as the stomach and the first segment of the small intestine, the duodenum, 
are bypassed (Figure 1.1b). A small proximal cardia pouch of the stomach (10-30 mL) is 
formed to receive ingested foods (Figure 1.1b). 
A systematic review and meta-analysis of several randomized control trial studies 
(RCTs)[4] has reported on the short-term (one to 2 years) clinical outcomes of patients 
who have undergone RYGB surgery,[5-7] and other bariatric surgical procedures 
(adjustable gastric banding (AGB), vertical sleeve gastrectomy, and biliopancreatic 
diversion)[6-9]. Results demonstrated significantly greater weight loss (short-term), with 
a reported mean difference of -26 kg (95% CI, -31 to -21; p<0.001) as well as a greater 
type 2 diabetes mellitus (T2DM) remission, with a reported relative risk (RR) of 22.1 




nonsurgical participants.[10] In addition, high-density cholesterol (HDL-C) and 
triglycerides were significantly improved among the surgical groups, and although 
medications for hypertension and other lipids were not shown to be significantly different 
between groups, some studies did report fewer use of medication for these conditions.[4, 
10] 
Two long-term prospective controlled intervention studies (non-RCTs) have been 
published, one a Utah study (6 years follow-up) including exclusively RYGB patients 
[11] and the other a Swedish Obesity Subjects (SOS) study (15 years follow-up) 
including RYGB (13%), AGB (19%) and vertical gastric banding (68%; procedure no 
longer performed)[12]. Remarkably, in the SOS surgical group, there was a 72% 
remission of T2DM at 2 years follow-up (OR 8.4, 95% CI 5.7 to 12.5; p<0.001) and at 10 
years follow-up, the T2DM remission was 36% (OR 3.5, 95% CI 1.6 to 7.3; 
p<0.001).[10, 12] In the Utah study, weight loss in the RYGB group was 34.9% (95% CI, 
33.9% to 35.8%) from baseline to year 2 and 27.7% (95% CI, 26.6% to 28.9%) from 
baseline to year 6. Weight gain for the control groups from baseline to year 6 was 0.2% 
(95% CI, -1.1% to 1.4%) and 0% (95% CI, -1.2% to 1.2%).[11] Diabetes remission at 
year 2 examination was 75% (95% CI, 63% to 87%), decreasing to 62% (95% CI, 49% to 
75%) at year 6. Further, the RYGB group had a 5- to 9-fold reduction in the risk of 
developing new diabetes when compared to the control groups.[11] As dramatic as the 
remission rate for diabetes following RYGB is, an equally impressive finding is rapid 
remission of diabetes within 2 days to 2 weeks after RYGB – long before significant 
weight loss,[13, 14] suggesting factors independent of weight loss are responsible for the 




Similar to the SOS study, our Utah study showed all major CVD risk factors 
(lipids, blood pressure, glucose, insulin, HbA1c) were significantly improved in the 
surgical group when compared to the 2 control groups.[11]  Reported remission rates of 
hypertension (6 years) were significantly improved in the surgical versus control group 
(42%, [95% CI, 32-52%] versus 18%, [95% CI 9-27%], OR, 2.9 [95% CI, 1.4-6.0] and 
42% versus 9%, [95% CI 3-15%], OR, 5.0 [95% CI, 2.1-11.9]). Further, the remission of 
low HDL-C rates were improved in the RYGB compared with control groups (67% [95% 
CI, 57-77%] versus 34%, [95% CI, 23-45%], OR, 3.8 [95% CI, 2.0-7.2] and 67% versus 
18%, [95% CI, 8-28%], OR, 6.2 [95% CI, 2.7-14.1]), and similar remission rates were 
reported for LDL-C and triglycerides.[11] 
The SOS study and a long-term retrospective controlled Utah study have also 
reported improved mortality for patients who have had bariatric surgery when compared 
to severely obese, nonoperated matched controls. The Utah study compared all-cause and 
cause-specific mortality for 7,925 RYGB patients compared to 7,925 weight- and age-
matched controls (1984-2002; average follow-up of 7.1 years) and reported a 40% 
reduction in all-cause mortality (HR 0.60; 95% CI, 0.45 to 0.67; p<0.001).[15] Similarly, 
the SOS study reported a 29% lower all-cause mortality (HR 0.71; 95% CI, 0.54 to 0.92; 
p<0.01) among the bariatric surgical group compared to matched controls after a 16-year 
total follow-up.[16]  
Finally, an on-going multicenter observational cohort study (NIH-funded) at 10 
US hospitals, referred to as the Longitudinal Assessment of Bariatric Surgery (LABS) 
Consortium, has recently published their 3-year follow-up results.[17] Of the 2,458 study 




weight loss was 31.5% (IQR, 24.6% to 38.4%; range, 59.2% loss to 0.9% gain) of 
baseline weight. The RYGB patients who had at least partial diabetes remission was 
67.5%, whereas remission of hypertension and dyslipidemia were 38.2% and 61.9%, 
respectively.[17] 
International experts attending the National Institutes of Health (NHLBI and 
NIDDK) recently convened to explore long-term outcomes following bariatric surgery 
(Bethesda, Maryland, May 2013) have identified a major knowledge gap in bariatric 
surgery is being able to identify factors (and patients) that might predict the long-term 
durability (success) of the surgery. Unfortunately, important metabolic measures related 
to metabolism (i.e., resting metabolic rate) and cardiorespiratory fitness have not been 
reported to date in relation to long-term weight changes following RYGB surgery. In 
addition, limited research relating to pregnancy outcomes in women who have 
participated in bariatric surgery has been reported and the association of age at RYGB 
surgery with long-term mortality has not been published. The aims of this study focused 
on addressing these potential predictive factors. 
As anticipated, the findings of the 3 proposed aims of this study did reveal 
specific outcomes that are likely to have predictive clinical value. The results of Aim 1 
demonstrated that favorable changes in CRF following RYGB surgery (i.e., from year 2 
to year 6) can have a positive influence upon reducing the risk of long-term weight regain 
following surgery (i.e., from year 2 to year 6). These findings also support clinical 
guidelines that recommend patients undergoing bariatric surgery should be well-informed 
of the importance to build in a lifetime of participation in physical activity following 




undergone gastric bypass surgery, Aim 2 clearly demonstrated that following Roux-en-Y 
gastric bypass (RYGB) surgery, women are at a significantly reduced risk for having a 
large-for-gestational-age (LGA) live birth. The results also indicated that post-RYGB 
surgery mothers are at a significantly greater risk to deliver a small-for-gestational-age 
(SGA) neonate. The increased risk for SGA delivery raises considerable clinical concern 
related to potential nutritional deficiencies for both the mother and the developing fetus. 
Greater exploration related to mechanisms that may account for the increased SGA risk 
following RYGB surgery as well as clinical surveillance of these SGA-born neonates 
during childhood, adolescence, and adulthood to determine long-term SGA outcomes are 
warranted. Finally, results of Aim 3 provided strong implication that gastric bypass 
surgery is protective against cardiovascular and cancer mortality for age groups greater 
than 34 years. With the exception of increased external causes of death in patients less 
than 35 years (i.e., suicide, poisonings of undetermined intent, and accidents not related 
to drugs), gastric bypass surgery also significantly reduces all-cause mortality rates, even 
for patients who undergo surgery at an older age. Further investigations are warranted to 
better understand and predict risk for externally-caused deaths among postgastric bypass 
patients, especially among surgical patients whose surgery is performed at an earlier age 
(i.e., less than 35 years). 
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